Current Studies

Our research program follows the evolution of the strain platform from Ceriporia lacerata CL-K1 to the third-generation Irpex lacteus strain. Current work focuses on mechanism validation, analytical characterization, safety, and translational study design.

Current Studies

CL-K1® current research pipeline

CL-K1® research continues to expand from completed safety, efficacy, and human clinical evidence into new animal efficacy studies and planned human research directions. This page will be updated as study designs, reports, and publishable results become available.

5Completed study categories archive
13Completed experiment entries listed
2Ongoing collaborations and studies
3Planned human research directions

Ongoing Studies

These studies are currently in progress. Public communication is limited to the research direction and collaboration status until the study designs, endpoints, and results are ready for formal disclosure.

Planned Studies

The next stage is planned around human application research. Study design, inclusion criteria, endpoints, and timing will be updated after protocols are confirmed.

Planned Human Study

Human blood glucose improvement study

A planned human study direction focused on blood glucose-related endpoints and broader metabolic health markers.

Planned Human Study

Human cognitive function study

A planned human study direction exploring cognitive function, aging-related markers, and overall health status.

Planned Human Study

Human liver function study

A planned human study direction focused on liver function, metabolic burden, and related biological indicators.

Completed Studies

Completed studies are organized as a study-category archive. The display follows a reverse evidence-development order, with later application-oriented studies shown before foundational safety studies.

Completed study categories archive: 5 categories and 13 completed experiment entries are listed below. Click each card to view the experiment names.

Research status, study designs, endpoints, and publication timing may change as protocols, testing reports, and regulatory review requirements are finalized. This page is provided for scientific and corporate communication purposes only and does not constitute medical advice, treatment claims, or guaranteed health outcomes.

Frequently Asked Questions

Frequently Asked Questions

Frequently Asked Questions

Frequently Asked Questions